Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2025. The report specifically details a transaction in the Company's own shares executed on August 27, 2025, and announced on August 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Shares Purchased | 2,875,831 |
| Price Range (pence) | 359.20 - 363.70 |
| Volume Weighted Average Price (pence) | 361.3796 |
| Post-Transaction Registered Capital | 8,963,475,311 ordinary shares |
| Treasury Shares Held | 3,880,205 |
| Voting Shares Outstanding | 8,959,595,106 |
Material Changes
The Company executed the second tranche of its share buyback programme, originally announced on July 31, 2025. The purchase of 2,875,831 shares for cancellation reduced the number of shares with voting rights to 8,959,595,106.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the buyback programme. The filing includes a standard disclaimer that the announcement does not constitute an offer or solicitation for securities. No specific guidance, risks, or contingencies regarding future operations are detailed in this specific report.
Investor Verification Checklist
- Verify the total remaining authorization under the share buyback programme announced on July 31, 2025.
- Confirm the updated share count for voting rights calculations (8,959,595,106) against the FCA's Disclosure Guidance and Transparency Rules.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular execution details.
- Check the Company's website for subsequent updates on the buyback programme status.